4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001209191-14-078157
Director sold 11,933 shares at an average $11.23 ($134,035)
- Director acquired 23,762 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Nash Duane · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-12-23 | Grant or award : show line 1 in the form | +23,762 | $11.54 | $274,213 | 23,762 | D |
| 2014-12-24 | Sale : show line 2 in the form | −6,764 | $11.26 | $76,189 | 16,998 | D |
| 2014-12-26 | Sale : show line 3 in the form | −5,169 | $11.19 | $57,846 | 11,829 | D |
| Open-market sales · 11,933 sh · avg $11.23 · $134,035 | ||||||
Loading xslF345X03/doc4.xml…